The options that dentists have in selling their dental practice have expanded dramatically over the last several years. The emergence of countless new DSOs, most of which have different models and value propositions, has added an element of complexity that most dentists do not know how to navigate. Five to seven years ago, the vast majority of dentists would not have considered selling to a DSO. That sentiment has changed, especially in the post-COVID era, and now dentists must be educated on countless points to consider when selling their practice to a corporate group. The equity models, valuation methodologies, operational support considerations, and capital that backs the broad universe of DSOs vary greatly. As dentists become savvier to dental practice transactions, the DSO landscape is changing at an even faster rate. This course is designed to highlight the most important questions dentists should ask a corporate buyer prior to engaging in the sale of their practice.

Course Objectives

• Understand the various equity models that DSOs typically use for partner dentists.

• Define the forms of capital used to purchase a dental practice.

• Identify commonly used transaction structures.

• Differentiate between earnings to a corporate group (EBITDA) and earnings to a practice owner.

• Outline a typical transaction process.

• Understand how a dental practice’s operations may change after selling to a DSO

Jake Berry

Jake Berry is MB2’s Chief Development Officer and has been with the group since 2017. Jake has broad experience in healthcare M&A advisory, capital investment planning, and financial planning and analysis. This background along with his military leadership experience enables him to help dentists understand the range of strategic options they have to maximize the equity value in their practice.